Maravai LifeSciences Announces Investor Conference Schedule for the Month of May 2021

Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following virtual investor conferences during the month of May.

On May 12, 2021, Kevin Herde, Chief Financial Officer, will participate in a fireside chat at the Bank of America Global Healthcare Conference at 10:15 a.m. PT.

On May 25, 2021, Carl Hull, Chief Executive Officer will participate in a fireside chat at the UBS Global Healthcare Conference at 2:00 p.m. PT.

A live webcast of the presentations will be available to all interested parties on the Maravai Lifesciences investor relations website at http://investors.maravai.com. An archived version of the webcast will be available a few hours following the completion of each event on the Maravai investor relations website.

About Maravai Maravai is a leading life sciences company providing critical products to enable the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. Maravai’s companies are leaders in providing products and services in the fields of nucleic acid synthesis, bioprocess impurity detection and analysis, and protein labeling and detection to many of the world's leading biopharmaceutical, vaccine, diagnostics, and cell and gene therapy companies.

For more information about Maravai LifeSciences, visit www.maravai.com.

Contact Information:
Media Contact: Sara Michelmore
MacDougall
[phone]
[e-mail]

Investor Contact: Deb Hart
Maravai LifeSciences
+ 1 858-988-5917
[e-mail]